JP Morgan analyst Casey Woodring maintains Hologic (NASDAQ:HOLX) with a Overweight and raises the price target from $90 to $95.
What 4 Analyst Ratings Have To Say About AXT
Over the past 3 months, 4 analysts have published their opinion on AXT (NASDAQ:AXTI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
